Add to ORKGNew delivery systems for amphotericin B applied to the improvement of leishmaniasis treatmen
Current drugs for the treatment of leishmaniasis are far from satisfactory and no effective vaccine ...
Tatiana G Ribeiro,1 Juçara R Franca,1 Leonardo L Fuscaldi,1 Mara L Santos,2 Mariana C Duarte,...
Amphotherin B was formulated in a nanosuspension as a new oral drug delivery system for the treatmen...
© 2015, Sociedade Brasileira de Medicina Tropical. All rights reserved. Leishmaniasis is one of the ...
In this review the benefits of using a drug delivery system (DDS) to improve therapeutic outcome wil...
PURPOSE OF REVIEW: Amphotericin B (AmpB) is considered the first-line treatment for visceral leishma...
Visceral leishmaniasis (VL) is caused by infection of the visceral reticuloendothelial system by Lei...
Leishmaniasis is a protozoan disease, which is responsible for response for major epidemics in many ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Natascia Bruni,1 Barbara Stella,2 Leonardo Giraudo,1 Carlo Della Pepa,2 Daniela Gastaldi,3 Franco Do...
Amphotericin B (Amp) has been well-successfully used to treat against Leishmania infection, although...
Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement and fa...
Purpose of review: Treatment of leishmaniasis is far from satisfactory: all antileishmanial drugs ar...
Amphotericin B (AmpB) is a polyene macrolide antibiotic used in the treatment of blood-borne parasit...
Cutaneous leishmaniasis (CL) is a neglected tropical disease. It presents as disfiguring and deformi...
Current drugs for the treatment of leishmaniasis are far from satisfactory and no effective vaccine ...
Tatiana G Ribeiro,1 Juçara R Franca,1 Leonardo L Fuscaldi,1 Mara L Santos,2 Mariana C Duarte,...
Amphotherin B was formulated in a nanosuspension as a new oral drug delivery system for the treatmen...
© 2015, Sociedade Brasileira de Medicina Tropical. All rights reserved. Leishmaniasis is one of the ...
In this review the benefits of using a drug delivery system (DDS) to improve therapeutic outcome wil...
PURPOSE OF REVIEW: Amphotericin B (AmpB) is considered the first-line treatment for visceral leishma...
Visceral leishmaniasis (VL) is caused by infection of the visceral reticuloendothelial system by Lei...
Leishmaniasis is a protozoan disease, which is responsible for response for major epidemics in many ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Natascia Bruni,1 Barbara Stella,2 Leonardo Giraudo,1 Carlo Della Pepa,2 Daniela Gastaldi,3 Franco Do...
Amphotericin B (Amp) has been well-successfully used to treat against Leishmania infection, although...
Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement and fa...
Purpose of review: Treatment of leishmaniasis is far from satisfactory: all antileishmanial drugs ar...
Amphotericin B (AmpB) is a polyene macrolide antibiotic used in the treatment of blood-borne parasit...
Cutaneous leishmaniasis (CL) is a neglected tropical disease. It presents as disfiguring and deformi...
Current drugs for the treatment of leishmaniasis are far from satisfactory and no effective vaccine ...
Tatiana G Ribeiro,1 Juçara R Franca,1 Leonardo L Fuscaldi,1 Mara L Santos,2 Mariana C Duarte,...
Amphotherin B was formulated in a nanosuspension as a new oral drug delivery system for the treatmen...